• Study on the Safety and Effectiveness of Ibrutinib for Children and Young Adults with Chronic Graft Versus Host Disease

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Spain

  • Study on Tocilizumab for Patients with Esophageal Cancer to Improve Chemoradiotherapy Outcomes

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on Nitric Oxide and Saline Nasal Sprays for Treating COVID-19 and Similar Illnesses in Primary Care Patients

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Ireland Poland Spain

  • Study of Durvalumab with Chemoradiation Therapy for Patients with Locally Advanced, Unresectable Esophageal Squamous Cell Carcinoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Poland Spain

  • Study of Abemaciclib with Irinotecan and Temozolomide for Children and Young Adults with Relapsed or Refractory Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on Eptinezumab for Preventing Chronic Migraine in Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Slovakia Spain

  • Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark France Germany +8

  • Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Ireland Italy +5

  • Study on the Effects of Selpercatinib in Patients Aged 12 and Older with Advanced Solid Tumors with RET Gene Alteration

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark France Germany Italy Spain

powered by